Category 10 of 10 · Medical Innovation

Medical Innovation

Advancing the frontiers of health and healing — translating discovery into care for those who need it most.

What this category recognises

Innovations that move beyond the laboratory and into the lives of patients, clinicians, and communities.

Medical Innovation honours young pioneers whose work in healthcare, medicine, or public health is reshaping how we prevent disease, treat patients, and deliver care. This award celebrates breakthroughs that do more than push scientific boundaries — they translate discovery into tangible, life-changing outcomes for real people, particularly those historically underserved by modern medicine.

The category encompasses novel therapeutics and diagnostics, surgical or clinical techniques, medical devices, digital health platforms, public health interventions, and frameworks that improve the quality, safety, or accessibility of care. What unites all qualifying work is a clear pathway from idea to impact.

Clinician reviewing medical scans on a screen in a hospital ward

Who should be nominated

Open to clinicians, researchers, and innovators of every background — provided their work demonstrably improves human health.

Clinician-innovators

Developed new protocols, devices, or treatment models adopted in clinical practice.

Biomedical researchers

Discoveries cited in clinical guidelines or advanced to active deployment.

Healthtech founders

Building solutions deployed at scale to patients or healthcare systems.

Public-health leaders

Designed and implemented programmes improving population health outcomes.

Accessible-tech inventors

Created medical technologies that bring quality care to low-resource or marginalised populations.

Cross-disciplinary innovators

Work bridging engineering, data, and clinical practice that has reached real patients.

How nominees are evaluated

Four domain-specific dimensions, on top of the five universal TOYP criteria.

All TOYP nominees are scored on Impact, Leadership, Innovation, Sustainability, and Inspiration. Within Medical Innovation, judges then look specifically at the four dimensions below.

Clinical Impact

Outstanding —

Innovations actively serving 10,000+ patients with outcomes data published or under regulatory review.

Pre-clinical work without human patient data is considered insufficient at this stage.

Novelty & Peer Validation

Outstanding —

Patents (granted or pending) alongside peer-reviewed publications, or citation in clinical guidelines / regulatory frameworks.

Independent expert validation is essential.

Equity & Access

Outstanding —

Solutions deliberately designed for affordability — costs at 30% or less of existing alternatives, or partnerships with public health systems.

A low-cost diagnostic deployed to 5,000 underserved patients can outpoint a premium therapeutic used by 10,000 high-income patients.

Regulatory Pathway & Safety

Outstanding —

HSA approval or equivalent international regulatory clearance with full safety profiles documented.

Ethics approvals, IRB oversight, and active safety monitoring are essential markers of credibility.

A higher standard for healing

Medical Innovation is, ultimately, about lives changed.

The ideal nominee is not merely brilliant — they are deeply purposeful, ethically rigorous, and committed to ensuring their breakthrough reaches those who need it most.

Read the full judging framework

Past Honourees · Medical Innovation